SolvencyTool logo
Rapporteringsforklaringer

Rapporteringsforklaringer

Hjem / Lover & Forskrifter / Rapporteringsforklaringer
S.01.01 Content of the submission
Document
S.02.01 Balance sheet
Document
S.05.01 Prem., claims & exp. – lobs
Document
S.12.01 Life & health SLT TP
Document
S.17.01 Non-life & health NSLT TP
Document
S.23.01 Own funds
Document
S.25.01 SCR – Standard formula
Document
S.28.01 MCR – Non-composites
Document
G.01.01 Content of the submission
Document
G.02.01 Balance sheet
Document
S.01.01 Content of the submission
Document
S.02.01 Balance sheet
Document
S.05.01 Prem., claims & exp. – lobs
Document
S.12.01 Life & health SLT TP
Document
S.17.01 Non-life & health NSLT TP
Document
S.23.01 Own funds
Document
S.25.01 SCR – Standard formula
Document
S.28.01 MCR – Non-composites
Document
G.01.01 Content of the submission
Document
G.02.01 Balance sheet
Document
G.05.01 Prem., claims & exp. – lobs
Document
G.23.01 Own funds
Document
G.25.01 SCR – Standard formula
Document
SE.01.01 Content of the submission
Document
SE.02.01 Balance sheet
Document
SE.06.02 List of assets
Document
E.01.01 Deposits to cedants
Document
E.02.01 Pension entitlements
Document
E.04.01 Investment revenues and expenses
Document
G.05.01 Prem., claims & exp. – lobs
Document
G.23.01 Own funds
Document
G.25.01 SCR – Standard formula
Document
SE.01.01 Content of the submission
Document
SE.02.01 Balance sheet
Document
SE.06.02 List of assets
Document
E.01.01 Deposits to cedants
Document
E.02.01 Pension entitlements
Document
E.04.01 Investment revenues and expenses
Document

Ingen dokumenter funnet

Sjekk malkoden (for eksempel S.02.01), eller prøv et kortere søkeord.

Mangler du en mal? Book en demo

EIOPA Solvency II

ECB E.01.01 Deposits to cedants ECB Taksonomi 2.8.0 ECB E.02.01 Pension entitlements ECB Taksonomi 2.8.0 ECB E.04.01 Investment revenues and expenses ECB Taksonomi 2.8.0 ECB SE.01.01 Content of the submission ECB Taksonomi 2.8.0 ECB SE.02.01 Balance sheet ECB Taksonomi 2.8.0 ECB SE.06.02 List of assets ECB Taksonomi 2.8.0 S.01.01 Content of the submission EIOPA Konsern Taksonomi 2.8.0 S.01.01 Content of the submission EIOPA Solo Taksonomi 2.8.0 S.01.02 Basic information EIOPA Konsern Taksonomi 2.8.0 S.01.02 Basic information EIOPA Solo Taksonomi 2.8.0 S.01.03 Basic information — RFF and matching adjustment portfolios EIOPA Konsern Taksonomi 2.8.0 S.01.03 Basic Information — RFF and matching adjustment portfolios EIOPA Solo Taksonomi 2.8.0 S.02.01 Balance sheet EIOPA Konsern Taksonomi 2.8.0 S.02.01 Balance sheet EIOPA Solo Taksonomi 2.8.0 S.02.02 Liabilities by currency EIOPA Konsern Taksonomi 2.8.0 S.02.02 Liabilities by currency EIOPA Solo Taksonomi 2.8.0 S.03.01 Off-balance sheet items — General EIOPA Konsern Taksonomi 2.8.0 S.03.01 Off-balance sheet items — General EIOPA Solo Taksonomi 2.8.0 S.04.02 Information on class 10 in Part A of Annex I of Solvency II Directive, excluding carrier's liability EIOPA Solo Taksonomi 2.8.0 S.04.03 Basic Information – List of underwriting entities EIOPA Solo Taksonomi 2.8.0 S.04.04 Activity by country – location of underwriting EIOPA Solo Taksonomi 2.8.0 S.04.05 Activity by country – location of risk EIOPA Solo Taksonomi 2.8.0 S.05.01 Premiums, claims and expenses by line of business EIOPA Konsern Taksonomi 2.8.0 S.05.01 Premiums, claims and expenses by line of business EIOPA Solo Taksonomi 2.8.0 S.05.02 Premiums, claims and expenses by country EIOPA Konsern Taksonomi 2.8.0 S.06.02 List of assets EIOPA Konsern Taksonomi 2.8.0 S.06.02 List of assets EIOPA Solo Taksonomi 2.8.0 S.06.03 Collective investment undertakings — look-through approach EIOPA Konsern Taksonomi 2.8.0 S.06.03 Collective investment undertakings — look-through approach EIOPA Solo Taksonomi 2.8.0 S.06.04 Climate change-related risks to investments EIOPA Solo Taksonomi 2.8.0 S.07.01 Structured products EIOPA Konsern Taksonomi 2.8.0 S.07.01 Structured products EIOPA Solo Taksonomi 2.8.0 S.08.01 Open derivatives EIOPA Konsern Taksonomi 2.8.0 S.08.01 Open derivatives EIOPA Solo Taksonomi 2.8.0 S.09.01 Information on gains / income and losses in the period EIOPA Konsern Taksonomi 2.8.0 S.09.01 Information on gains/income and losses in the period EIOPA Solo Taksonomi 2.8.0 S.10.01 Securities lending and repos EIOPA Konsern Taksonomi 2.8.0 S.10.01 Securities lending and repos EIOPA Solo Taksonomi 2.8.0 S.11.01 Assets held as collateral EIOPA Konsern Taksonomi 2.8.0 S.11.01 Assets held as collateral EIOPA Solo Taksonomi 2.8.0 S.12.01 Life and Health SLT Technical Provisions EIOPA Solo Taksonomi 2.8.0 S.12.02 Life and Health SLT Technical Provisions — by Country EIOPA Solo Taksonomi 2.8.0 S.13.01 Projection of future gross cash flows (Best Estimate — Life) EIOPA Solo Taksonomi 2.8.0 S.14.01 Life obligations analysis EIOPA Solo Taksonomi 2.8.0 S.14.02 Non-Life obligation analysis EIOPA Solo Taksonomi 2.8.0 S.14.03 Cyber underwriting risk EIOPA Solo Taksonomi 2.8.0 S.16.01 Information on annuities stemming from Non-Life Insurance obligations EIOPA Solo Taksonomi 2.8.0 S.17.01 Non-life Technical Provisions EIOPA Solo Taksonomi 2.8.0 S.17.03 Non-Life Technical Provisions — By country EIOPA Solo Taksonomi 2.8.0 S.18.01 Projection of future cash flows (Best Estimate — Non Life) EIOPA Solo Taksonomi 2.8.0 S.19.01 Non-life insurance claims EIOPA Solo Taksonomi 2.8.0 S.20.01 Development of the distribution of the claims incurred EIOPA Solo Taksonomi 2.8.0 S.21.01 Loss distribution risk profile EIOPA Solo Taksonomi 2.8.0 S.21.02 Underwriting risks non-life EIOPA Solo Taksonomi 2.8.0 S.21.03 Non-life distribution of underwriting underwriting risks — by sum insured EIOPA Solo Taksonomi 2.8.0 S.22.01 Impact of long term guarantees measures and transitionals EIOPA Solo Taksonomi 2.8.0 S.22.01 Impact of long-term guarantees measures and transitionals EIOPA Konsern Taksonomi 2.8.0 S.22.02 Projection of future cash flows (Best Estimate — Matching portfolios) EIOPA Solo Taksonomi 2.8.0 S.22.03 Information on the matching adjustment calculation EIOPA Solo Taksonomi 2.8.0 S.22.04 Information on the transitional on interest rates calculation EIOPA Solo Taksonomi 2.8.0 S.22.05 Overall calculation of the transitional on technical provisions EIOPA Solo Taksonomi 2.8.0 S.22.06 Best estimate subject to volatility adjustment by country and currency EIOPA Solo Taksonomi 2.8.0 S.23.01 Own Funds EIOPA Konsern Taksonomi 2.8.0 S.23.01 Own Funds EIOPA Solo Taksonomi 2.8.0 S.23.02 Detailed information by tiers on own funds EIOPA Konsern Taksonomi 2.8.0 S.23.02 Detailed information by tiers on own funds EIOPA Solo Taksonomi 2.8.0 S.23.03 Annual movements on own funds EIOPA Konsern Taksonomi 2.8.0 S.23.03 Annual movements on own funds EIOPA Solo Taksonomi 2.8.0 S.23.04 List of items on own funds EIOPA Konsern Taksonomi 2.8.0 S.23.04 List of items on own funds EIOPA Solo Taksonomi 2.8.0 S.24.01 Participations held EIOPA Solo Taksonomi 2.8.0 S.25.01 Solvency Capital Requirement — for groups on Standard Formula EIOPA Konsern Taksonomi 2.8.0 S.25.01 Solvency Capital Requirement — for undertakings on Standard Formula EIOPA Solo Taksonomi 2.8.0 S.25.05 Solvency Capital Requirement - for groups using an internal model (partial or full) EIOPA Konsern Taksonomi 2.8.0 S.25.05 Solvency Capital Requirement — for undertakings using an internal model (partial or full) EIOPA Solo Taksonomi 2.8.0 S.26.01 Solvency Capital Requirement — Market risk EIOPA Konsern Taksonomi 2.8.0 S.26.01 Solvency Capital Requirement — Market risk EIOPA Solo Taksonomi 2.8.0 S.26.02 Solvency Capital Requirement — Counterparty default risk EIOPA Konsern Taksonomi 2.8.0 S.26.02 Solvency Capital Requirement — Counterparty default risk EIOPA Solo Taksonomi 2.8.0 S.26.03 Solvency Capital Requirements — Life underwriting risk EIOPA Konsern Taksonomi 2.8.0 S.26.03 Solvency Capital Requirements — Life underwriting risk EIOPA Solo Taksonomi 2.8.0 S.26.04 Solvency Capital Requirement — Health underwriting risk EIOPA Konsern Taksonomi 2.8.0 S.26.04 Solvency Capital Requirement — Health underwriting risk EIOPA Solo Taksonomi 2.8.0 S.26.05 Solvency Capital Requirement — Non-Life underwriting risk EIOPA Konsern Taksonomi 2.8.0 S.26.05 Solvency Capital Requirement — Non-Life underwriting risk EIOPA Solo Taksonomi 2.8.0 S.26.06 Solvency Capital Requirements — Operational risk EIOPA Konsern Taksonomi 2.8.0 S.26.06 Solvency Capital Requirements — Operational risk EIOPA Solo Taksonomi 2.8.0 S.26.07 Solvency Capital Requirement — Simplifications EIOPA Konsern Taksonomi 2.8.0 S.26.07 Solvency Capital Requirement — Simplifications EIOPA Solo Taksonomi 2.8.0 S.26.08 Solvency Capital Requirement - for groups using an internal model (partial or full) EIOPA Konsern Taksonomi 2.8.0 S.26.08 Solvency Capital Requirement — for undertakings using an internal model (partial or full) EIOPA Solo Taksonomi 2.8.0 S.26.09 Internal model: Market & Credit risk – for financial instruments EIOPA Konsern Taksonomi 2.8.0 S.26.09 Internal model: Market and Credit risk – for financial instruments EIOPA Solo Taksonomi 2.8.0 S.26.10 Internal model: Credit event risk – portfolio view details EIOPA Konsern Taksonomi 2.8.0 S.26.10 Internal model: Credit event risk – portfolio view details EIOPA Solo Taksonomi 2.8.0 S.26.11 Internal model: Credit risk – details for financial instruments EIOPA Konsern Taksonomi 2.8.0 S.26.11 Internal model: Credit risk – details for financial instruments EIOPA Solo Taksonomi 2.8.0 S.26.12 Internal model: Credit risk – for non-financial instruments EIOPA Konsern Taksonomi 2.8.0 S.26.12 Internal model: Credit risk – for non-financial instruments EIOPA Solo Taksonomi 2.8.0 S.26.13 Internal model: Non-Life & Health NSLT Underwriting risk EIOPA Konsern Taksonomi 2.8.0 S.26.13 Internal model: Non-Life & Health NSLT Underwriting risk EIOPA Solo Taksonomi 2.8.0 S.26.14 Internal model: Life and Health underwriting risk EIOPA Konsern Taksonomi 2.8.0 S.26.14 Internal model: Life and Health underwriting risk EIOPA Solo Taksonomi 2.8.0 S.26.15 Internal model: Operational risk EIOPA Konsern Taksonomi 2.8.0 S.26.15 Internal model: Operational risk EIOPA Solo Taksonomi 2.8.0 S.26.16 Internal model - Model Changes EIOPA Konsern Taksonomi 2.8.0 S.26.16 Internal model - Model Changes EIOPA Solo Taksonomi 2.8.0 S.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk EIOPA Konsern Taksonomi 2.8.0 S.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk EIOPA Solo Taksonomi 2.8.0 S.28.01 Minimum Capital Requirement — Only life or only non-life insurance or reinsurance activity EIOPA Solo Taksonomi 2.8.0 S.28.02 Minimum Capital Requirement — Both life and non-life insurance activity EIOPA Solo Taksonomi 2.8.0 S.29.01 Excess of Assets over Liabilities EIOPA Solo Taksonomi 2.8.0 S.29.02 Excess of Assets over Liabilities — explained by investments and financial liabilities EIOPA Solo Taksonomi 2.8.0 S.29.03 Excess of Assets over Liabilities — explained by technical provisions EIOPA Solo Taksonomi 2.8.0 S.29.04 Detailed analysis per period — Technical flows versus Technical provisions EIOPA Solo Taksonomi 2.8.0 S.30.01 Facultative covers for non-life and life business basic data EIOPA Solo Taksonomi 2.8.0 S.30.02 Facultative covers for non-life and life business shares data EIOPA Solo Taksonomi 2.8.0 S.30.03 Outgoing Reinsurance Program basic data EIOPA Solo Taksonomi 2.8.0 S.30.04 Outgoing Reinsurance Program shares data EIOPA Solo Taksonomi 2.8.0 S.31.01 Share of reinsurers (including Finite Reinsurance and SPV's) EIOPA Konsern Taksonomi 2.8.0 S.31.01 Share of reinsurers (including Finite Reinsurance and SPV's) EIOPA Solo Taksonomi 2.8.0 S.31.02 Special Purpose Vehicles EIOPA Konsern Taksonomi 2.8.0 S.31.02 Special Purpose Vehicles EIOPA Solo Taksonomi 2.8.0 S.32.01 Undertakings in the scope of the group EIOPA Konsern Taksonomi 2.8.0 S.33.01 Insurance and reinsurance individual requirements EIOPA Konsern Taksonomi 2.8.0 S.34.01 Other regulated and non-regulated financial undertakings including insurance holding companies and mixed financial holding companies EIOPA Konsern Taksonomi 2.8.0 S.35.01 Contribution to group Technical Provisions EIOPA Konsern Taksonomi 2.8.0 S.36.01 IGT — Equity-type transactions, debt and asset transfer EIOPA Konsern Taksonomi 2.8.0 S.36.01 IGT — Equity-type transactions, debt and asset transfer EIOPA Solo Taksonomi 2.8.0 S.36.02 IGT — Derivatives EIOPA Konsern Taksonomi 2.8.0 S.36.02 IGT — Derivatives EIOPA Solo Taksonomi 2.8.0 S.36.03 IGT — Off-balance sheet and contingent liabilities EIOPA Konsern Taksonomi 2.8.0 S.36.03 IGT — Off-balance sheet and contingent liabilities EIOPA Solo Taksonomi 2.8.0 S.36.04 IGT — Insurance and Reinsurance EIOPA Konsern Taksonomi 2.8.0 S.36.04 IGT — Insurance and Reinsurance EIOPA Solo Taksonomi 2.8.0 S.36.05 IGT — P&L EIOPA Konsern Taksonomi 2.8.0 S.36.05 IGT — Profit and Loss EIOPA Solo Taksonomi 2.8.0 S.36.06 IGT — Off-balance sheet and contingent liabilities EIOPA Solo Taksonomi 2.8.0 S.36.07 IGT — Insurance and Reinsurance EIOPA Solo Taksonomi 2.8.0 S.37.01 Risk concentration – Exposure to Counterparties EIOPA Konsern Taksonomi 2.8.0 S.37.02 Risk Concentration – Exposure by currency, sector, country EIOPA Konsern Taksonomi 2.8.0 S.37.03 Risk Concentration — Exposure by asset class and rating EIOPA Konsern Taksonomi 2.8.0

BOE Insurance

AoC.01 Analysis of Change in Solvency Capital Requirement BOE PS 15/24 · 2024 IM.00 Internal model risk output - Content of the submission and Basic information BOE PS 15/24 · 2024 IM.01 Internal model outputs (life) BOE PS 15/24 · 2024 IM.02 Internal model counterparty risk BOE PS 15/24 · 2024 IM.03 Internal model outputs (non-life) BOE PS 15/24 · 2024 IR.01.01 Content of the submission BOE PS 15/24 · 2024 IR.01.02 Basic information BOE PS 15/24 · 2024 IR.01.03 Basic information – RFF and matching adjustment portfolios BOE PS 15/24 · 2024 IR.01.04 Basic information – Branch legal entity BOE PS 15/24 · 2024 IR.02.01 Balance sheet BOE PS 15/24 · 2024 IR.02.02 Assets and liabilities by currency BOE PS 15/24 · 2024 IR.02.03 Additional branch balance sheet information BOE PS 15/24 · 2024 IR.03.01 Off-balance sheet items — general BOE PS 15/24 · 2024 IR.03.02 Off-balance sheet items —unlimited guarantees received BOE PS 15/24 · 2024 IR.03.03 Off-balance sheet items — unlimited guarantees provided BOE PS 15/24 · 2024 IR.05.02 Premiums, claims and expenses by country BOE PS 15/24 · 2024 IR.05.03 Life income and expenditure BOE PS 15/24 · 2024 IR.05.04 Non-life income, expenditure and business model analysis BOE PS 15/24 · 2024 IR.05.05 Life premiums and claims by country BOE PS 15/24 · 2024 IR.05.06 Non-life premiums and claims by country BOE PS 15/24 · 2024 IR.05.07 Business model analysis - financial guarantee insurers BOE PS 15/24 · 2024 IR.05.08 Material pooling arrangements BOE PS 15/24 · 2024 IR.05.09 Assessable mutuals BOE PS 15/24 · 2024 IR.05.10 .01 – Excess capital generation BOE PS 15/24 · 2024 IR.06.02 List of assets BOE PS 15/24 · 2024 IR.06.03 Collective investment undertakings — look-through approach BOE PS 15/24 · 2024 IR.08.01 Open derivatives BOE PS 15/24 · 2024 IR.09.01 Information on income/gains and losses in the period BOE PS 15/24 · 2024 IR.10.01 Securities lending and repos BOE PS 15/24 · 2024 IR.11.01 Assets held as collateral BOE PS 15/24 · 2024 IR.12.01 Life technical provisions BOE PS 15/24 · 2024 IR.12.03 Life best estimate liabilities by country BOE PS 15/24 · 2024 IR.12.04 best estimate assumptions for life insurance risks BOE PS 15/24 · 2024 IR.12.05 with-profits value of bonus BOE PS 15/24 · 2024 IR.12.06 with-profits liabilities and assets BOE PS 15/24 · 2024 IR.14.01 Life obligations analysis BOE PS 15/24 · 2024 IR.16.01 Non-life annuities information BOE PS 15/24 · 2024 IR.16.02 Non-life annuities projection of future cash flows BOE PS 15/24 · 2024 IR.17.01 Non-life technical provisions BOE PS 15/24 · 2024 IR.17.03 Non-life best estimate liabilities by country BOE PS 15/24 · 2024 IR.18.01 Non-life projection of future cash flows BOE PS 15/24 · 2024 IR.18.02 Non-life liability projection of future cash flows BOE PS 15/24 · 2024 IR.19.01 .01 — Non-life insurance claims BOE PS 15/24 · 2024 IR.19.02 Non-life general liability claim development BOE PS 15/24 · 2024 IR.20.01 Development of the distribution of the claims incurred BOE PS 15/24 · 2024 IR.21.02 .01 — Non-life underwriting risks BOE PS 15/24 · 2024 IR.21.04 Cyber underwriting risk BOE PS 15/24 · 2024 IR.22.01 Impact of long term guarantees measures and transitionals BOE PS 15/24 · 2024 IR.22.04 Information on the transitional on interest rates calculation BOE PS 15/24 · 2024 IR.22.07 Best estimate subject to volatility adjustment by currency BOE PS 15/24 · 2024 IR.23.01 Own Funds BOE PS 15/24 · 2024 IR.23.02 Detailed information by tiers on own funds BOE PS 15/24 · 2024 IR.23.03 Annual movements on own funds BOE PS 15/24 · 2024 IR.23.04 List of items on own funds BOE PS 15/24 · 2024 IR.23.05 Society of Lloyd’s own funds and capital requirements BOE PS 15/24 · 2024 IR.24.01 Participations held BOE PS 15/24 · 2024 IR.25.04 Solvency Capital Requirement BOE PS 15/24 · 2024 IR.25.05 Solvency Capital Requirement – Partial or full internal model components BOE PS 15/24 · 2024 IR.25.06 Solvency Capital Requirement – loss-absorbing capacity of deferred taxes BOE PS 15/24 · 2024 IR.26.01 Solvency Capital Requirement – Market risk BOE PS 15/24 · 2024 IR.26.02 Solvency Capital Requirement – Counterparty default risk BOE PS 15/24 · 2024 IR.26.03 Solvency Capital Requirement – Life underwriting risk BOE PS 15/24 · 2024 IR.26.04 Solvency Capital Requirement – Health underwriting risk BOE PS 15/24 · 2024 IR.26.05 Solvency Capital Requirement — Non-Life underwriting risk BOE PS 15/24 · 2024 IR.26.06 Solvency Capital Requirement — Operational risk BOE PS 15/24 · 2024 IR.26.07 Solvency Capital Requirement — Simplifications BOE PS 15/24 · 2024 IR.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk BOE PS 15/24 · 2024 IR.28.01 .01 — Minimum Capital Requirement — Only life or only non-life activity BOE PS 15/24 · 2024 IR.28.02 .01 — Minimum Capital Requirement — Both life and non-life activity BOE PS 15/24 · 2024 IR.30.03 Non-life outwards reinsurance contract information BOE PS 15/24 · 2024 IR.30.04 Non-life outwards reinsurance contract reinsurer exposures BOE PS 15/24 · 2024 IR.30.05 Reinsurer and collateral provider entity information BOE PS 15/24 · 2024 IR.30.06 Life outwards reinsurance summary BOE PS 15/24 · 2024 IR.30.07 Life outwards proportional reinsurance BOE PS 15/24 · 2024 IR.30.08 Life outwards non-proportional reinsurance BOE PS 15/24 · 2024 IR.31.01 Outwards reinsurance balance sheet exposures BOE PS 15/24 · 2024 IR.32.01 Undertakings in the scope of the group BOE PS 15/24 · 2024 IR.33.01 Insurance and reinsurance individual requirements BOE PS 15/24 · 2024 IR.34.01 Other regulated and non-regulated financial undertakings BOE PS 15/24 · 2024 IR.35.01 Contribution to group technical provisions BOE PS 15/24 · 2024 IR.36.01 IGT — equity-type transactions, debt and asset transfer BOE PS 15/24 · 2024 IR.36.02 IGT — derivatives BOE PS 15/24 · 2024 IR.36.04 IGT — cost sharing, contingent liabilities, off BS and other items BOE PS 15/24 · 2024 IRR.22.02 Matching adjustment portfolio projection of future cash flows BOE PS 15/24 · 2024 IRR.22.03 Matching adjustment calculation BOE PS 15/24 · 2024 MALIR – Matching adjustment asset and liability information return: Content of the submission, basic information and analytical data BOE PS 15/24 · 2024 MR.01.02 Market risk sensitivities BOE PS 15/24 · 2024 QMC.01 Quarterly model change BOE PS 15/24 · 2024

Få tilgang til Solvency II

Og hold deg oppdatert om de siste oppdateringene, finansielle resultater og kunngjøringer

Be om demo